Clinical Trials Research Alliance (CTRA)

For Researchers

The Wright State University and Premier Health Clinical Trials Research Alliance offers a range of support to both clinical research investigators and basic science investigators. One of the alliance’s most important functions is to bring these often disparate groups together to promote translational research.

The CTRA fosters robust collaborations between basic scientists and clinicians in order to accelerate translational research.

Collaboration among investigators makes the resulting research plan more compelling to a government or industry organization willing to sponsor the research necessary to make laboratory discoveries available to patients in a clinical trial environment.

Clinical Trials Research Alliance (CTRA) and Investigator-Initiated Clinical Trials/Clinical Research Policy Statement

CTRA’s Services to Clinical Research Investigators

The Wright State University and Premier Health Clinical Trials Research Alliance provides clinical researchers with significant assistance in setting up a clinical trial and managing the clinical trial process.

Identifying and Securing Research Opportunities
The CTRA regularly meets with industry and government sponsors and maintains a pipeline of clinical trial opportunities based on the researcher’s area of interest. The CTRA assists in the development of research proposals. This help includes budgeting, contract negotiation, ethical consultation, and protocol development to turn those research opportunities into contracted trials.

CTRA primarily works with industry-sponsored clinical trials but is also available to support investigator-initiated clinical trials. In addition to Phase 1 through 3, the CTRA supports with Phase 4 trials that monitor how a newly FDA approved drug is being introduced into the community. 

Comprehensive Trial Support
Once the trial has been awarded, the CTRA provides assistance with all stages of the process. The CTRA’s Clinical Research Manager oversees all trials, bringing proven project management skills and extensive clinical experience to each trial to ensure its timely completion with quality results.

The CTRA helps with IRB submission, regulatory requirements, patient recruitment, informed consent, quality assurance and monitoring, and data management. Access to trained and experienced clinical trial coordinators is also available. The CTRA provides subject advocacy assistance through the alliance’s Community Advisory Board, and the CTRA will provide assistance if the trial must be concluded prematurely. CTRA will help identify statistical and manuscript support for publishing clinical trial results.

Promoting Translational Research Collaborations
The CTRA recognizes the importance of strong, bi-directional information exchange between clinical research investigators and basic research scientists to foster creative solutions to today’s healthcare problems.

The alliance promotes collaborations through:

  • the CTRA website where investigators’ work and current research interests are highlighted. To find researchers with similar interests, visit CTRA Investigators.
  • consultations with CTRA staff and Boonshoft School of Medicine faculty who have knowledge of the research being done in both the clinical and the basic research environments in the Dayton region.
  • gatherings to encourage the development of professional relationships among those who share research interests.

The research office at Wright State University’s Boonshoft School of Medicine funds grants for investigator-initiated trials to provide initial results to secure a larger trial opportunity. The Translational Research Development Grant Program provides a mechanism to link basic scientists with clinician-investigators. It promotes innovative translational clinical research programs that have a high probability of attracting external funding or have potential for generating intellectual property and commercialization. Learn more about this grant program.

CTRA’s Services to Basic Science Investigators

The CTRA strives to advance translational research by accelerating the process of transferring laboratory discoveries into treatments for patients. It also supports the translation of clinical observations back to the laboratory for further testing.

Promoting Translational Research Collaborations
The CTRA recognizes the importance of strong, bi-directional information exchange between clinical research investigators and basic research scientists to foster creative solutions to today’s healthcare problems.

The alliance promotes collaborations through:

  • the CTRA website where investigators’ work and current research interests are highlighted. To find researchers with similar interests, visit CTRA Investigators.
  • consultations with CTRA staff and Boonshoft School of Medicine faculty who have knowledge of the research being done in both the clinical and the basic research environments in the Dayton region.
  • gatherings to encourage the development of professional relationships among those who share research interests.

Translational Research Grant Support
Today’s research grants require scientists to demonstrate how their research will flow to the community. Working with clinical research investigators will accelerate this process by adding their expertise in providing medical care to patients.

The CTRA regularly meets with industry and government organizations who sponsor trials, promoting the exciting research being done in Dayton.

The research office at Wright State University’s Boonshoft School of Medicine funds grants for investigator-initiated trials to provide initial results to secure a larger trial opportunity. The Translational Research Development Grant Program provides a mechanism to link basic scientists with clinician-investigators. It promotes innovative translational clinical research programs that have a high probability of attracting external funding or have potential for generating intellectual property and commercialization. Learn more about this grant program.

Last edited on 09/27/2018.